SCHEMBL258987

SCHEMBL258987

COC(=O)N(CCCN(CCCN(C(=O)OC)C1c2ccccc2-c2ccccc21)C(=O)CCC(=O)O)C1c2ccccc2-c2ccccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.37
CYP2D6 P10635 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
SLC6A3 Q01959 1/20 0.36
KDM4A O75164 1/20 0.34
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
PHF8 Q9UPP1 1/20 0.34
KDM2A Q9Y2K7 1/20 0.34
PKM P14618 1/20 0.34
ACHE P22303 1/20 0.34
GAA P10253 2/20 0.33
POLB P06746 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
USP2 O75604 1/20 0.33
TSHR P16473 1/20 0.33
KDM4E B2RXH2 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16718185 0.88 KMT2A (0.43) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL1001580 0.87 KMT2A (0.45) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL3202976 0.86 KMT2A (0.40) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL31355071 0.86 KMT2A (0.40) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL4922980 0.85 KMT2A (0.47) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL5840878 0.85 KMT2A (0.47) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL18298160 0.81 SLC22A2 (0.38) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL28900959 0.80 CYP2D6 (0.39) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL27486738 0.79 SLC22A2 (0.38) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL2173884 0.79 ALDH1A1 (0.39) KMT2ACYP2D6SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8133985-B2 Peptide nucleic acids conjugated with multi-amine linkers and nucleic acid detecting device using the same PANAGENE INC. (KR) 2012-03-13 US disclosed
US-20090312197-A1 PEPTIDE NUCLEIC ACIDS CONJUGATED WITH MULTI-AMINE LINKERS AND NUCLEIC ACID DETECTING DEVICE USING THE SAME PANAGENE INC. (KR) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312197-A1 PEPTIDE NUCLEIC ACIDS CONJUGATED WITH MULTI-AMINE LINKERS AND NUCLEIC ACID DETECTING DEVICE USING THE SAME NPPA, PARN, PARG KMT2A 548/4885CYP2D6 4652/4885SLC6A2 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.